Daigremontianin

Daigremontianin is a cardiac glycoside found in certain species of the genus Kalanchoe, particularly Kalanchoe daigremontiana. This compound is known for its potent biological activity, which can have significant effects on the cardiovascular system.
Chemical Structure[edit]
Daigremontianin is characterized by its complex chemical structure, which includes a steroidal core linked to a sugar moiety. The structure of daigremontianin is similar to other cardiac glycosides, such as digoxin and ouabain, which are known for their ability to inhibit the sodium-potassium pump (Na_/K_-ATPase) in cardiac cells.
Biological Activity[edit]
Daigremontianin exerts its effects primarily through the inhibition of the Na_/K_-ATPase enzyme. This inhibition leads to an increase in intracellular sodium levels, which subsequently affects calcium exchange and increases intracellular calcium concentrations. The elevated calcium levels enhance cardiac contractility, making daigremontianin a potent positive inotropic agent.
Toxicity[edit]
While daigremontianin has potential therapeutic applications, it is also highly toxic. Ingestion of plants containing daigremontianin can lead to symptoms of cardiac glycoside poisoning, which include nausea, vomiting, diarrhea, confusion, and potentially fatal cardiac arrhythmias. Therefore, caution is advised when handling plants known to contain this compound.
Uses[edit]
In traditional medicine, plants containing daigremontianin have been used for their purported health benefits, although such uses are not widely supported by scientific evidence. Modern research is exploring the potential therapeutic applications of daigremontianin and related compounds, particularly in the treatment of certain heart conditions.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian